Interim analyses of the multinational real-world prospective cohort HEM-POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A.
European journal of haematology
View this publicationEuropean journal of haematology
View this publicationThe Lancet. Haematology
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publicationJournal of thrombosis and haemostasis : JTH
View this publicationJournal of thrombosis and haemostasis : JTH
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publicationResearch and practice in thrombosis and haemostasis
View this publicationTherapeutic advances in hematology
View this publicationEuropean journal of haematology
View this publicationAdvances in therapy
View this publication